Sudeep Pharma Lists at Strong Premium as Investors React to Heavily Subscribed IPO

Sudeep Pharma delivered a robust stock market debut today, listing at ₹730 on the NSE a 23.1% premium to its issue price of ₹593. The shares later climbed above ₹792 as trading momentum strengthened. The ₹895 crore IPO included ₹95 crore of fresh equity and an ₹800 crore offer for sale from promoter groups. Proceeds will support machinery purchases and general corporate needs.